Seroquel :: Multiple pharmacies comparison.

DUBLIN, Ireland — Research and Markets (http://www.researchandmarkets.com/reports/c53479) has announced the addition of the Decision Resources, Inc report: Bipolar Disorder: Can Competitive Advantage Be Established in a Chall…

July 22, 2004 (Philadelphia) — Caregivers of Alzheimer’s patients know all too well the behavioral problems, such as agitation, that often accompany the memory loss seen in Alzheimer’s disease. But researchers have now found that a medication may help tame agitation.

Agitation associated with Alzheimer’s disease is the No. 1 reason that dementia patients are admitted to nursing homes…

Oct. 11, 2006 — The antipsychotic drugs Zyprexa, Seroquel, and Risperdal may help some Alzheimer’s patients, but their side effects should be carefully weighed, a new study shows.
The 36-week study, published in The New England Journal of Medicine, included 421 people with Alzheimer’s-related …

Dr. Rob Long–I was greatly distressed to learn that your client Hillary Clinton had stabbed you in the eye with a pencil. As I’m sure you know, the best predictor of violent behavior is past violent behavior, so I was surprised at your lack of precaution with this particular woman.
Be that as it may, as a colleague, I wanted to offer some consultation on the case. Regarding medications, …

M2 PRESSWIRE-11 July 2007-Biotech News: Trade Alert for AstraZeneca plc(C)1994-2007 M2 COMMUNICATIONS LTD RDATE:11072007 Trade Alert for AstraZeneca plc (NYSE:AZN) AstraZeneca PLC discovers, develops, manufactures, and markets prescription pharmaceuticals in the areas of cardiovascular, gastrointestinal, neuroscience, oncology, respiratory and inflammation, and infection worldwide.

Most Popular
10 Jobs That Pay $…

Most Popular
5 Regular Mistakes In Public Speaking
Public Speaking: 7 Secrets Of Great Public Speakers
10 Jobs That Pay $30 An Hour
13 Job Interview Mistakes To Avoid
3 Questions No Job Seeker Ever Wants To Be Asked?

> M2 PRESSWIRE-5 April 2007-Research and Markets: Only Eli Lillys Symbyax and AstraZenecas Seroquel have Received FDA Approval for Treat…

LONDON, Oct. 10, 2008–AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets for the acute treatment of the depressive episodes associate…

M2 PRESSWIRE-29 February 2008-MB Alerts: AstraZeneca Submits sNDA for SEROQUEL XR(TM) for the Treatment of Major Depressive Disorder(C)1994-2008 M2 COMMUNICATIONS LTD
RDATE:29022008

Most Popular
13 Job Interview Mistakes To Avoid
10 Jobs That Pay $30 An Hour
3 Questions No Jo…

THE FDA HAS asked AstraZeneca to halt distribution of a professional sales aid used to market its antipsychotic medication Seroquel.
In a warning letter sent to AstraZeneca, the PDA’s Division of Drug Marketing, Advertising & Communications (DDMAC) wrote that the sales aid is misleading because it …

FREMONT, Calif., July 31 /PRNewswire/ — Handa Pharmaceuticals, LLC (”Handa”), a specialty pharmaceutical company based in Fremont, California, today confirmed that its Abbreviated New Drug Application (”ANDA”) for Quetiapine Fumarate Extended-Release Tablets, the generic version of AstraZeneca’s SEROQUEL(R) XR, has been accepted for filing by the U.S. Food and Drug Administration (”FDA”). Based upon available information, Handa believes that it is the first applicant to file an AND…